Search for: "Sanofi-Aventis"
Results 81 - 100
of 563
Sorted by Relevance
|
Sort by Date
30 Aug 2009, 9:43 pm
Sun Pharmaceutical Industries Ltd. et al. 3:09-cv-04333; filed August 24, 2009 in the District Court of New Jersey • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
28 Sep 2009, 9:05 pm
Class Action Complaint Alleging Securities Fraud Violations Arising from Disclosures Concerning Drug under Development Failed to State Claims under Section 10(b) of the Securities Exchange Act of 1934 or Rule 10b-5 New York Federal Court Holds Plaintiffs filed a putative class action against French pharmaceutical company Sanofi-Aventis and certain individual defendants alleging violations of the Securities Exchange Act of 1934; specifically, the class action complaint alleged that… [read post]
7 Jan 2017, 4:24 pm
The whistleblower in the Sanofi Aventis case assists the government in stopping fraud by Sanofi Aventis, by exposing the company’s illegal marketing tactics and illegal bribes to physicians to push taxotere. [read post]
7 Jan 2017, 4:24 pm
The whistleblower in the Sanofi Aventis case assists the government in stopping fraud by Sanofi Aventis, by exposing the company’s illegal marketing tactics and illegal bribes to physicians to push taxotere. [read post]
2 Jan 2008, 9:12 am
Finally, in October 2007 the FDA posted on its web site a copy of an 11-page "Warning Letter" to Sanofi-Aventis about problems with Ketek Study 3014. [read post]
30 Jul 2008, 5:37 pm
Sanofi-Aventis (Fed. [read post]
18 Jun 2008, 11:05 am
French drugmaker Sanofi-Aventis plans to make a 40.04 billion Czech crown ($2.57 billion) offer for Czech drugmaker Zentiva, trumping a bid from financial group PPF. [read post]
25 Jul 2010, 3:18 pm
According to media reports, a $15.36 million settlement has been reached in New York federal court between drug maker Sanofi-Aventis SA and more than 5,000 female employees who claim they were discriminated against. [read post]
27 Mar 2007, 5:07 am
A deal between Sanofi-Aventis, France’s largest drug company, and U.S. rival Bristol-Myers Squibb could still be in the offing. [read post]
20 Oct 2010, 7:05 am
The following is excerpted from an October 20, 2010 article by Victoria Slind-Flor at Bloomberg: Sanofi-Aventis SA won a $442 million judgment against Apotex Inc. in a lawsuit over the patent for the blood thinner Plavix. [read post]
7 Jan 2010, 1:47 pm
Following feedback from the United States FDA for additional clinical data, the French drug marker Sanofi-Aventis lately withdrawn both US and EU marketing authorization applications for insomnia drug Eplivanserin (protected by the US Patent No. 5166416). [read post]
14 Jul 2009, 9:55 pm
District Court for the District of New Jersey has issued an order announcing a settlement of all outstanding litigation between Sanofi-Aventis and Ebewe Pharma over Eloxatin ®, a colon cancer drug marketed and distributed by Sanofi. [read post]
2 Feb 2011, 2:27 pm
The drug, which is manufactured by Sanofi-Aventis, is currently in Phase III clinical trials. [read post]
2 Jun 2009, 2:56 pm
The Department of Justice announced last week that it has entered into a multi-million dollar civil settlement agreement with Aventis Pharmaceutical, Inc., a subsidiary of Sanofi Aventis U.S. [read post]
27 Apr 2007, 10:46 am
Seton Hall Law School announced a new Center for Health and Pharmaceutical Law, endowed by Schering-Plough Corporation, sanofi-aventis, Johnson Johnson, and Bristol-Myers Squibb, as well as an expansion of the law school's Institute of Law, Science, and Technology, endowed by... [read post]
31 Jan 2011, 10:38 am
So says Reuters: U.S. biotech company Genzyme Corp and French drugmaker Sanofi-Aventis SA have reached an agreement in principle on the outlines of a merger deal, three sources familiar with the situation said on Monday. [read post]
24 Oct 2008, 12:09 pm
Trista Kelley from Bloomberg.com reports this morning that European regulators have pulled Sanofi-Aventis, SA's obesity pill, Acomplia, citing concerns about its side effects. [read post]
6 Nov 2013, 11:00 pm
In Sanofi-Aventis v. [read post]
30 Apr 2014, 10:00 pm
The Federal Circuit decision in Sanofi-Aventis Deutschland GmbH v. [read post]
28 Mar 2007, 7:44 pm
By Jason Derry --- Sanofi-Aventis and Oxford BioMedica have announced an agreement under which the two companies will jointly develop and market TroVax ® for treating and preventing cancer. [read post]
